SCHEMBL3095111

SCHEMBL3095111

Nc1ccc(-c2ccc3nc(N)nn3c2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 10/20 0.51
PIK3CG P48736 10/20 0.51
PIK3CA P42336 6/20 0.51
PIK3CB P42338 2/20 0.51
DYRK1A Q13627 2/20 0.49
MAP4K4 O95819 2/20 0.49
PAK4 O96013 1/20 0.49
CSF1R P07333 1/20 0.49
RET P07949 1/20 0.49
GRK5 P34947 1/20 0.49
MAPK8 P45983 1/20 0.49
CSNK1A1 P48729 1/20 0.49
ACVR1 Q04771 1/20 0.49
PTK2 Q05397 1/20 0.49
TYRO3 Q06418 1/20 0.49
MAP4K2 Q12851 1/20 0.49
IKBKE Q14164 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
DYRK1B Q9Y463 1/20 0.49
ABL1 P00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997011 0.80 PIK3CG (0.48) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL1933137 0.80 PIK3CG (0.52) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL12909569 0.79 PIK3CG (0.59) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL614711 0.78 RET (0.61) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
Hydrochloric Acid SCHEMBL938808 0.77 PIK3CG (0.58) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL12909565 0.77 PIK3CG (0.50) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL939045 0.77 PIK3CG (0.54) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL3101946 0.76 PIK3CG (0.68) PIK3CDPIK3CGPIK3CAPIK3CB
Hydrochloric Acid SCHEMBL933897 0.75 PIK3CG (0.49) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A
SCHEMBL12909571 0.75 PIK3CG (0.59) PIK3CDPIK3CGPIK3CAPIK3CBDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883820-B2 Triazole derivatives as kinase inhibitors CELLZOME LTD. (GB) 2014-11-11 US claimed
US-20100227800-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS CELLZOME LIMITED (GB) 2010-09-09 US claimed
EP-2057158-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS Cellzome Limited (GB) 2009-05-13 EP claimed
WO-2008025821-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS CELLZOME LIMITED (GB) 2008-03-06 WO claimed
EP-2057158-B1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS CELLZOME LTD (GB) 2015-08-12 EP disclosed
US-8883820-B2 Triazole derivatives as kinase inhibitors CELLZOME LTD. (GB) 2014-11-11 US disclosed
US-20100227800-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS CELLZOME LIMITED (GB) 2010-09-09 US disclosed
EP-2057158-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS Cellzome Limited (GB) 2009-05-13 EP disclosed
WO-2008025821-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS CELLZOME LIMITED (GB) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227800-A1 TRIAZOLE DERIVATIVES AS KINASE INHIBITORS ITK, PIK3C3, TXK PIK3CD 19/4885PIK3CG 55/4885PIK3CA 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.